As of May 2024 Celldex Therapeutics has a market cap of $2.64 Billion. This makes Celldex Therapeutics the world's 3714th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $2.64 B | 21.89% |
2023 | $2.16 B | 3.32% |
2022 | $2.09 B | 16.26% |
2021 | $1.80 B | 160.23% |
2020 | $0.69 B | 1733.29% |
2019 | $37.84 M | 6.63% |
2018 | $35.49 M | -90.81% |
2017 | $0.38 B | 7.75% |
2016 | $0.35 B | -76.84% |
2015 | $1.54 B | -5.36% |
2014 | $1.63 B | -24.33% |
2013 | $2.16 B | 400.33% |
2012 | $0.43 B | 276.23% |
2011 | $0.11 B | -13.09% |
2010 | $0.13 B | -10.75% |
2009 | $0.14 B | 18.32% |
2008 | $0.12 B | 237.13% |
2007 | $37.09 M | -62.96% |
2006 | $0.10 B | -28.18% |
2005 | $0.13 B | -6.42% |
2004 | $0.14 B | -15.96% |
2003 | $0.17 B | 158.92% |
2002 | $68.47 M | -71.75% |
2001 | $0.24 B |
On May 14th, 2024 the market cap of Celldex Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Pfizer PFE | $161.15 B | 5,995.98% | ๐บ๐ธ USA |
Amgen AMGN | $167.05 B | 6,218.91% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $93.41 B | 3,433.66% | ๐ฌ๐ง UK |
Titan Pharmaceuticals
TTNP | $6.16 M | -99.77% | ๐บ๐ธ USA |
Seagen
SGEN | $43.15 B | 1,532.38% | ๐บ๐ธ USA |
Agenus
AGEN | $0.23 B | -91.19% | ๐บ๐ธ USA |
Emergent BioSolutions
EBS | $0.28 B | -89.38% | ๐บ๐ธ USA |